China's Oppo edged South Korea's Samsung to become the top vendor in the Southeast Asian smartphone market in the second quarter with a 20.3 percent market share.
Samsung Electronics Co. dropped to the second spot with a market share of 19.5 percent in the April-June period, according to industry tracker Counterpoint Research.
Oppo was one of the Chinese brands that took four of the top five spots.
The others were Vivo, which came in third with 17.9 percent, followed by Xiaomi with 14 percent, and Realme taking the fifth spot with 12.8 percent.
Samsung first lost its top vendor spot in Southeast Asia to Oppo in the fourth quarter of 2019 but recaptured it in the first quarter of this year with an 18.9 percent market share, which was 0.2 percent higher than Oppo.
According to Counterpoint Research, the pandemic prompted Southeast Asian consumers to settle for budget smartphones, which were the ones manufactured by China.
Smartphone shipments in Southeast Asia plummeted 22 percent on-year to 24 million units in the second quarter.


China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Google Secures Pentagon AI Deal for Classified Projects 



